Literature DB >> 22476960

Trade-offs in defensive metabolite production but not ecological function in healthy and diseased sponges.

Deborah J Gochfeld1, Haidy N Kamel, Julie B Olson, Robert W Thacker.   

Abstract

Diseases of marine organisms, and sponges in particular, are increasingly reported worldwide. Prior research indicates that the survival of sponges on reefs is due largely to their production of biologically active secondary metabolites that provide protection from a diversity of stressors. Aplysina Red Band Syndrome (ARBS) is an emerging disease affecting Caribbean rope sponges (Aplysina spp.), but it is not known whether secondary metabolites play a role in disease susceptibility and resistance. To investigate whether differences in secondary metabolites may explain variability in susceptibility to ARBS in Aplysina cauliformis, we used high performance liquid chromatography (HPLC) to generate chemical profiles from healthy tissue in both healthy and diseased sponges, and quantified peak areas for 15 metabolites. Analyses of healthy and diseased sponges revealed qualitative and quantitative differences in their chemical profiles. Aplysamine-1 and fistularin-3 were produced in significantly higher concentrations by healthy sponges, whereas aerothionin and 11-oxoaerothionin were found only in diseased sponges. At natural concentrations, extracts from both healthy and diseased sponges deterred feeding by an omnivorous reef fish. Fistularin-3 deterred feeding at concentrations found in healthy sponges, but not at concentrations found in diseased sponges. Aerothionin deterred feeding at concentrations found in diseased sponges, and may at least partially replace the loss of fistularin-3 as a feeding deterrent compound following pathogenesis, suggesting a trade-off in the production of feeding deterrent compounds. Extracts from healthy and diseased sponges inhibited bacterial growth, and both aplysamine-1 and fistularin-3 displayed selective antibacterial activity. Despite differences in secondary metabolite production between healthy and diseased sponges, the stress associated with ARBS does not appear to compromise the ability of A. cauliformis to maintain defenses against some of its natural enemies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476960     DOI: 10.1007/s10886-012-0099-5

Source DB:  PubMed          Journal:  J Chem Ecol        ISSN: 0098-0331            Impact factor:   2.626


  26 in total

Review 1.  Chemical defenses: from compounds to communities.

Authors:  Valerie J Paul; Karen E Arthur; Raphael Ritson-Williams; Cliff Ross; Koty Sharp
Journal:  Biol Bull       Date:  2007-12       Impact factor: 1.818

Review 2.  Sponge disease: a global threat?

Authors:  Nicole S Webster
Journal:  Environ Microbiol       Date:  2007-06       Impact factor: 5.491

3.  Immune defenses of healthy, bleached and diseased Montastraea faveolata during a natural bleaching event.

Authors:  Laura D Mydlarz; Courtney S Couch; Ernesto Weil; Garriet Smith; C Drew Harvell
Journal:  Dis Aquat Organ       Date:  2009-11-16       Impact factor: 1.802

4.  Chemistry of verongida sponges. 9.1 secondary metabolite composition of the caribbean sponge aplysina cauliformis

Authors: 
Journal:  J Nat Prod       Date:  1999-04       Impact factor: 4.050

5.  The pathology of sponge orange band disease affecting the Caribbean barrel sponge Xestospongia muta.

Authors:  Hilde Angermeier; Janine Kamke; Usama R Abdelmohsen; Georg Krohne; Joseph R Pawlik; Niels L Lindquist; Ute Hentschel
Journal:  FEMS Microbiol Ecol       Date:  2010-11-30       Impact factor: 4.194

6.  Allocation of chemical and structural defenses in the sponge Melophlus sarasinorum.

Authors:  Sven Rohde; Peter J Schupp
Journal:  J Exp Mar Bio Ecol       Date:  2011-03-15       Impact factor: 2.171

7.  The future of coral reefs.

Authors:  N Knowlton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

8.  Shifts in microbial and chemical patterns within the marine sponge Aplysina aerophoba during a disease outbreak.

Authors:  Nicole S Webster; Joana R Xavier; Marnie Freckelton; Cherie A Motti; Rose Cobb
Journal:  Environ Microbiol       Date:  2008-09-08       Impact factor: 5.491

9.  Fistularin 3 and 11-ketofistularin 3. Feline leukemia virus active bromotyrosine metabolites from the marine sponge Aplysina archeri.

Authors:  S P Gunasekera; S S Cross
Journal:  J Nat Prod       Date:  1992-04       Impact factor: 4.050

10.  Depth-related alkaloid variation in Mediterranean Aplysina sponges.

Authors:  Annika Putz; Anne Kloeppel; Martin Pfannkuchen; Franz Brümmer; Peter Proksch
Journal:  Z Naturforsch C J Biosci       Date:  2009 Mar-Apr
View more
  5 in total

1.  Secondary Metabolome Variability and Inducible Chemical Defenses in the Mediterranean Sponge Aplysina cavernicola.

Authors:  M Reverter; T Perez; A V Ereskovsky; B Banaigs
Journal:  J Chem Ecol       Date:  2016-01-12       Impact factor: 2.626

2.  Competition induces allelopathy but suppresses growth and anti-herbivore defence in a chemically rich seaweed.

Authors:  Douglas B Rasher; Mark E Hay
Journal:  Proc Biol Sci       Date:  2014-01-08       Impact factor: 5.349

3.  Transmission studies and the composition of prokaryotic communities associated with healthy and diseased Aplysina cauliformis sponges suggest that Aplysina Red Band Syndrome is a prokaryotic polymicrobial disease.

Authors:  Matteo Monti; Aurora Giorgi; Cole G Easson; Deborah J Gochfeld; Julie B Olson
Journal:  FEMS Microbiol Ecol       Date:  2022-01-11       Impact factor: 4.194

4.  Spatial variability in secondary metabolites of the indo-pacific sponge Stylissa massa.

Authors:  Sven Rohde; Deborah J Gochfeld; Sridevi Ankisetty; Bharathi Avula; Peter J Schupp; Marc Slattery
Journal:  J Chem Ecol       Date:  2012-05-09       Impact factor: 2.626

5.  Exploring individual- to population-level impacts of disease on coral reef sponges: using spatial analysis to assess the fate, dynamics, and transmission of Aplysina Red Band Syndrome (ARBS).

Authors:  Cole G Easson; Marc Slattery; Henrique G Momm; Julie B Olson; Robert W Thacker; Deborah J Gochfeld
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.